Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Kanglaite Injection
DRUG
2 trials
Sponsors
KangLaiTe USA
, Zhejiang Kanglaite Pharmaceutical Co.Ltd
Conditions
Cancer Cachexia
Stage IV NSCLC
Phase 2
Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer
Terminated
NCT01640730
KangLaiTe USA
Stage IV NSCLC
Start: 2012-05-31
End: 2012-10-31
Updated: 2014-01-16
Phase 4
A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia
NCT02553187
Zhejiang Kanglaite Pharmaceutical Co.Ltd
Cancer Cachexia
Start: 2015-09-30
End: 2018-07-31
Target: 160
Updated: 2017-02-15